Nova Biomedical Corporation
Developer and manufacturer of whole-blood, point-of-care, critical-care and cell-culture diagnostic analyzers and consumables. Operates product development, prototyping, and global manufacturing sites and provides contract development and manufacturing services for medical devices and diagnostics. Maintains ISO 13485 and MDSAP certifications and multiple FDA 510(k) clearances. In 2025 the company combined with an analytical-instrumentation business through a transaction announced in March 2025 and operates as a unified organization under the Nova Biomedical name.
Industries
Nr. of Employees
Very Large (1000+)
Nova Biomedical Corporation
Nova Biomedical Corporation, 200 Prospect Street, Waltham, MA 02454-9141, USA
Patents
Disposable electrochemical biosensor based on NAD(P)-dependent dehydrogenase and diaphorase
US-12064243-B2
View Details
Disposable electrochemical biosensor based on NAD(P)-dependent dehydrogenase and diaphorase
US-12064243-B2
View DetailsProducts
Point-of-care whole-blood glucose and metabolite meters
Handheld and hospital-grade meter systems with disposable biosensor strips intended for bedside glucose, lactate, ketone and creatinine testing with designs to reduce analytical interference.
Multi-parameter blood gas and critical-care analyzers
Bench and bedside analyzers for rapid measurement of blood gases, electrolytes, metabolites and hemoglobin fractions using disposable sensor cartridges to minimize maintenance.
Automated cell-culture and bioprocess analyzers
Automated analyzers for cell culture and fermentation monitoring that measure metabolites, gases, pH, osmolality and cell density/viability with small sample volumes and integration options for automated sampling systems.
Laboratory reference glucose analyzers
Bench reference analyzers intended for laboratory reference testing, device calibration and validation use in clinical and manufacturing laboratories.
Veterinary and emergency services analyzers
Portable meters and small analyzers adapted for veterinary critical care and pre-hospital/ambulance use measuring lactate, hemoglobin, hematocrit, glucose, ketones and creatinine.
Osmolality and laboratory analytical instruments (acquired portfolio)
Laboratory osmometers and associated analytical instrumentation and controls added through integration of an analytical-instrumentation business to expand laboratory testing capabilities.
Point-of-care whole-blood glucose and metabolite meters
Handheld and hospital-grade meter systems with disposable biosensor strips intended for bedside glucose, lactate, ketone and creatinine testing with designs to reduce analytical interference.
Multi-parameter blood gas and critical-care analyzers
Bench and bedside analyzers for rapid measurement of blood gases, electrolytes, metabolites and hemoglobin fractions using disposable sensor cartridges to minimize maintenance.
Automated cell-culture and bioprocess analyzers
Automated analyzers for cell culture and fermentation monitoring that measure metabolites, gases, pH, osmolality and cell density/viability with small sample volumes and integration options for automated sampling systems.
Laboratory reference glucose analyzers
Bench reference analyzers intended for laboratory reference testing, device calibration and validation use in clinical and manufacturing laboratories.
Veterinary and emergency services analyzers
Portable meters and small analyzers adapted for veterinary critical care and pre-hospital/ambulance use measuring lactate, hemoglobin, hematocrit, glucose, ketones and creatinine.
Osmolality and laboratory analytical instruments (acquired portfolio)
Laboratory osmometers and associated analytical instrumentation and controls added through integration of an analytical-instrumentation business to expand laboratory testing capabilities.
Services
End-to-end product development, prototyping, regulatory support and dedicated manufacturing for medical devices and diagnostics using focused factories and dedicated teams.
In-person seminars and on-demand webinar series covering clinical topics (blood gas, ionized electrolytes, glucose meter accuracy, cell-culture monitoring) delivered with continuing education credit approvals where indicated.
SDS request portal and distribution for product lines, enabling access to chemical and reagent safety documentation.
End-to-end product development, prototyping, regulatory support and dedicated manufacturing for medical devices and diagnostics using focused factories and dedicated teams.
In-person seminars and on-demand webinar series covering clinical topics (blood gas, ionized electrolytes, glucose meter accuracy, cell-culture monitoring) delivered with continuing education credit approvals where indicated.
SDS request portal and distribution for product lines, enabling access to chemical and reagent safety documentation.
Expertise Areas
- Point-of-care and critical-care clinical diagnostics
- Bioprocess and cell-culture monitoring instrumentation
- Electrochemical biosensor and reagent development
- Contract product development and focused-factory manufacturing for medical devices
Key Technologies
- Electrochemical biosensing (potentiometric and amperometric)
- Direct potentiometry for electrolytes
- Spectrophotometry / photometry
- Conductivity-based sensors
News & Updates
Company participation and exhibit at AARC Congress 2025 in Phoenix, AZ.
In-person educational seminar on bedside glucose testing and meter accuracy held in New Orleans; program approved for AACN CERPs and P.A.C.E. continuing education credits.
In-person educational seminar on bedside glucose testing and meter accuracy held in Dearborn, MI; program approved for AACN CERPs and P.A.C.E. continuing education credits.
Integration of an analytical-instrumentation organization in 2025 to expand laboratory and bioprocess measurement capabilities.
510(k) clearance allowing capillary glucose testing with critically ill patients for a hospital glucose meter system.
Quality management system certifications and MDSAP registration confirming compliance with multiple national regulatory requirements.
Company participation and exhibit at AARC Congress 2025 in Phoenix, AZ.
In-person educational seminar on bedside glucose testing and meter accuracy held in New Orleans; program approved for AACN CERPs and P.A.C.E. continuing education credits.
In-person educational seminar on bedside glucose testing and meter accuracy held in Dearborn, MI; program approved for AACN CERPs and P.A.C.E. continuing education credits.
Integration of an analytical-instrumentation organization in 2025 to expand laboratory and bioprocess measurement capabilities.
510(k) clearance allowing capillary glucose testing with critically ill patients for a hospital glucose meter system.
Quality management system certifications and MDSAP registration confirming compliance with multiple national regulatory requirements.